Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4017G | ISIN: US69833W4042 | Ticker-Symbol: N/A
München
20.09.24
08:01 Uhr
0,380 Euro
0,000
0,00 %
1-Jahres-Chart
PANBELA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PANBELA THERAPEUTICS INC 5-Tage-Chart
GlobeNewswire (Europe)
571 Leser
Artikel bewerten:
(2)

Delisting of Securities of Northern Revival Acquisition Corporation; Veradigm Inc.; Neptune Wellness Solutions Inc.; Panbela Therapeutics, Inc.; Bit Brother Limited; Nocturne Acquisition Corporation; View, Inc. and others from The Nasdaq Stock Market

Finanznachrichten News

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares, unit, and warrants of Northern Revival Acquisition Corporation. Northern Revival Acquisition Corporation's securities were suspended on February 15, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Veradigm Inc. Veradigm Inc.'s securities were suspended on February 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Neptune Wellness Solutions Inc. Neptune Wellness Solutions Inc.'s securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Panbela Therapeutics, Inc. Panbela Therapeutics, Inc.'s securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bit Brother Limited. Bit Brother Limited's securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, rights, and units of Nocturne Acquisition Corporation. Nocturne Acquisition Corporation's securities were suspended on April 4, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock and warrants of View, Inc. View, Inc.'s securities were suspended on April 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Casa Systems, Inc. Casa Systems, Inc.'s securities were suspended on April 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Gamida Cell Ltd. Gamida Cell Ltd.'s securities were suspended on April 8, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.'s securities were suspended on April 11, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.'s securities were suspended on April 12, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Motus GI Holdings, Inc. Motus GI Holdings, Inc.'s securities were suspended on April 16, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of ProSomnus, Inc. ProSomnus, Inc.'s securities were suspended on April 18, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Mobile Global Esports Inc. Mobile Global Esports Inc.'s securities were suspended on April 18, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.